Autoimmunity & Inflammation Program

 

The Autoimmunity and Inflammation Program includes research into the origins and therapeutic modulation of autoimmune destruction of the islet in Type 1 diabetes and into the role of inflammation in Type 2 diabetes. Research within the program has led to novel insights into the surveillance of islet antigens leading to type 1 diabetes, the central role of the breakdown in T cell tolerance in that immune attack on the islet and the role of the immune system in reducing the response of tissues to insulin, leading to type 2 diabetes.

 

Autoimmunity & Inflammation Program Members and Research Activities:

Abul Abbas, MBBS

Mark Anderson, MD, PhD

Mark Ansel, PhD

Jeffrey Bluestone, PhD

Jason Cyster, PhD

Hans Dooms, PhD

Suneil Koliwad, MD

Matthew Krummel, PhD

Lewis Lanier, PhD

Richard Locksley, MD

Michael McManus, PhD

Steven Rosen, PhD

Qizhi Tang, PhD

Arthur Weiss, MD, PhD

David Wofsy, MD

 

CENTER MEMBERS ARE REMINDED TO ACKNOWLEDGE DRC CENTER GRANT (P30 DK063720) CONTRIBUTIONS WITH ‘THIS RESEARCH WAS SUPPORTED BY GRANTS X, Y FROM NIH P30 DK063720'.